MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Long-term Safety of Medical Cannabis in Parkinson’s disease: a retrospective case-control study

    T. Goldberg, Y. Redlich, T. Fay-Karmon, S. Hassin-Baer, S. Anis (Tel Aviv, Israel)

    Objective: This study aims to evaluate the effects of long-term treatment with medical cannabis (MC) on the course of Parkinson’s disease (PD), with a focus…
  • 2022 International Congress

    Focused ultrasound offers tremor relief in multiple system atrophy patients

    M. Nassar, A. Sinai, L. Shornikov, I. Erikh, M. Constantinescu, M. Zaaroor, I. Schlesinger (Haifa, Israel)

    Objective: To report on the efficacy and safety of MRI-guided focused ultrasound (FUS) VIM-thalamotomy in patients with multiple system atrophy (MSA). Background: FUS has established…
  • 2022 International Congress

    Quality of life and patient reported outcomes with subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 BeyoND study

    W. Poewe, F. Stocchi, L. Adar, T. Yardeni, A. Espay (Innsbruck, Austria)

    Objective: To review quality of life and other patient reported outcomes data from the ND0612 BeyoND study. Background: ND0612 is in development as a continuous,…
  • 2022 International Congress

    Correlations between cognitive impairments and brain abnormalities in Wilson disease: a systematic review

    A. Hausmann, S. Kannenberg, C. Hartmann, J. Caspers, A. Schnitzler (Duesseldorf, Germany)

    Objective: To provide an overview of brain regions involved in cognitive impairment (CI) in Wilson disease (WD) with the aim of understanding pathomechanisms. Background: WD…
  • 2022 International Congress

    Comparison of Disease Progression in Patients with Brain-first versus Body-first Parkinson’s Disease

    DW. Ryu, SW. Yoo, KS. Lee, SG. Ha, JS. Kim (Seoul, Republic of Korea)

    Objective: This study aimed to compare the clinical progression between brain-first and body-first PD groups using cardiac sympathetic denervation (CSD). Background: Brain-first and body-first Parkinson’s…
  • 2022 International Congress

    Invisible DBS-lead fixation using a patient-specific burr-hole cover

    L. Stieglitz (Zurich, Switzerland)

    Objective: Deep brain stimulation (DBS) leads need to be securely fixed at the burr-hole after implantation. Commercial devices for this purpose have to be placed…
  • 2022 International Congress

    COMPARISON OF COMPLICATIONS OF POST-COVID-19 IN PATIENTS WITH PARKINSONISM SYNDROME OF DIFFERENT GENESIS

    O. Tondiy (Kharkiv, Ukraine)

    Objective: The background of our study was the presence or absence of changes in motor and non-motor disorders in patients with Parkinson's syndrome of various origins…
  • 2022 International Congress

    Analyzing gait videos to identify and evaluate spinocerebellar ataxia types 1 and 3

    P. Yang, M. Hasan, W. Rahman, M. Islam, T. Olubajo, J. Thaker, A. Abdelkader, E. Hoque, T. Ashizawa (Rochester, USA)

    Objective: To analyze videos of gait to: 1) identify spinocerebellar ataxia types 1 and 3, and 2) predict scores on the gait task section of…
  • 2022 International Congress

    Basal forebrain contribution to cognitive deficits during medication “off” state in Parkinson’s disease

    D. Lench, T. Turner, E. Woolbright, F. Rodriguez-Porcel, G. Revuelta (Charleston, USA)

    Objective: We sought to determine whether structural integrity of cholinergic Basal Forebrain (BF) was associated with subjective cognitive deficits experienced during medication “off” time Parkinson’s…
  • 2022 International Congress

    BRAIN REGIONAL HYPOMETABOLISM PROGRESSION IN iRBD: THE COGNITIVE ROLE OF OCCIPITAL HYPOMETABOLISM

    G. Carli, S. Meles, A. Janzen, D. Perani, W. Oertel, K. Leenders (Groningen, Netherlands)

    Objective: To understand functional brain changes over time in isolated REM sleep behaviour disorder (iRBD), we investigated the progression of regional hypometabolism in iRBD patients…
  • « Previous Page
  • 1
  • …
  • 146
  • 147
  • 148
  • 149
  • 150
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley